ResearcherSahlgrenska University HospitalActive in the last 2 years

Eva Philipson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-7862-5628; OpenAlex author ID A5063094212. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Accumulation of p62/sequestosome-1 in pancreatic cancer progression: association with inflammation and immune cell infiltration. Co-author DOI 10.1016/j.pan.2026.07.005 ↗
High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer. Co-author DOI 10.1186/s12885-022-09468-6 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Johan Bourghardt Fagman · 2 shared papers, 2022–2026 · strength 0.61
- Paper Accumulation of p62/sequestosome-1 in pancreatic cancer progression: association with inflammation and immune cell infi… DOI 10.1016/j.pan.2026.07.005 ↗
- Paper High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer. DOI 10.1186/s12885-022-09468-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.